These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14990720)

  • 21. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.
    Ostler T; Davidson W; Ehl S
    Eur J Immunol; 2002 Aug; 32(8):2117-23. PubMed ID: 12209623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
    Ostler T; Ehl S
    Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice.
    Eichinger KM; Egaña L; Orend JG; Resetar E; Anderson KB; Patel R; Empey KM
    Respir Res; 2015 Oct; 16():122. PubMed ID: 26438053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    Wronski S; Dannenmaier J; Schild S; Macke O; Müller L; Burmeister Y; Seilheimer B; Müller M
    PLoS One; 2018; 13(4):e0195822. PubMed ID: 29672626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
    de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
    Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.
    Haynes LM; Caidi H; Radu GU; Miao C; Harcourt JL; Tripp RA; Anderson LJ
    J Infect Dis; 2009 Aug; 200(3):439-47. PubMed ID: 19545210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection.
    Shao HY; Huang JY; Lin YW; Yu SL; Chitra E; Chang CK; Sung WC; Chong P; Chow YH
    Int J Infect Dis; 2015 Dec; 41():56-64. PubMed ID: 26555647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes.
    Hansson J; Dohlsten M; Sjögren HO; Hedlund G
    Eur J Immunol; 1995 Jan; 25(1):75-9. PubMed ID: 7843256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity.
    Ware CF; Sanchez-Madrid F; Krensky AM; Burakoff SJ; Strominger JL; Springer TA
    J Immunol; 1983 Sep; 131(3):1182-8. PubMed ID: 6193178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
    Graham BS; Davis TH; Tang YW; Gruber WC
    Pediatr Res; 1993 Aug; 34(2):167-72. PubMed ID: 8233720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.
    Shi H; Ren K; Lv B; Zhang W; Zhao Y; Tan RX; Li E
    Sci Rep; 2016 Oct; 6():35851. PubMed ID: 27767097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells.
    Lu X; McCoy KS; Xu J; Hu W; Chen H; Jiang K; Han F; Chen P; Wang Y
    Virus Res; 2015 Jan; 195():162-71. PubMed ID: 25451068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
    Zhang W; Tripp RA
    J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.
    Cannon MJ; Openshaw PJ; Askonas BA
    J Exp Med; 1988 Sep; 168(3):1163-8. PubMed ID: 3262705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.